Prioritize Children When Developing Antibacterial Agents

  14 June 2022

There is a significant lag time before determining the appropriate dosing regimen for new antibacterial agents given to children.

Of the 24 approved antimicrobials, 20 were for use in adults alone for indications that included acute bacterial skin infections and community-acquired pneumonia. Of those 20, six were approved and labeled for patients younger than 18 years old, with the period of approval for adults and children ranging from 20 to 195 months. In addition, 11 of the 14 that have not been labeled for children have yet to complete PREA requirements.

Author(s): Aaron Tallent
Kids and Carers  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre


JSS University


Global Ambassador Network

Welcome at the AMR Insights Ambassador Network!

The AMR Insights Ambassador Network is a growing, distinctive group of professionals who stand out for their commitment, willingness to cooperate and open attitude to combat Antimicrobial resistance (AMR).

More information and free-of-charge registration
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!